TransEnterix (TRXC) : During the past 4 weeks, traders have been relatively bearish on TransEnterix (TRXC), hence the stock is down -7.21% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.91% relative to the S&P 500. The 4-week change in the price of the stock is -7.33% and the stock has fallen -1.42% in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.84% and the 50-Day Moving Average is 3.56%.The 200 Day SMA reached 43.45%. TransEnterix, Inc. has dropped 22.78% during the last 3-month period . Year-to-Date the stock performance stands at -43.95%.
TransEnterix (NYSEMKT:TRXC): After opening at $1.37, the stock dipped to an intraday low of $1.35 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $1.41 and the buying power remained strong till the end. The stock closed at $1.39 for the day, a gain of 1.46% for the day session. The total traded volume was 260,869. The stocks close on the previous trading day was $1.37.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.